Skip to Content

Research & Funding

Past Other NCI & NIH InitiativesRSS

This page lists past other NCI and NIH cancer imaging initiatives, including grant mechanisms.

Requests for Application (RFA) are usually announced with special application dates; there is no possibility for applying after that date. Program Announcements (PA, PAR) may be open for a set period of time, such as 3 years or less; applications submitted in response to Program Announcements may be due on the standard dates (February 1, June1, and October 1) or may have special dates for receipt of applications. Please pay attention to these dates. Contact a CIP staff member if you have questions.

  • RFA-AI-06-030: Radionuclide decorporation agents for radiation/nuclear emergencies: project bioshield (R01) (NIAID)

    • Release Date: March 30, 2006

    This is a funding opportunity announcement (FOA) to accelerate the development of safe and effective products to remove radionuclides from the body (decorporation) following nuclear contamination from any source. Specifically, candidate products will demonstrate an increase in efficiency and rate of radionuclide elimination from the body after contamination due to ingestion, inhalation or transdermal absorption.

    See full description in NIH Guide:RFA-AI-06-030

  • PA-06-295: Etiology, prevention, and treatment of hepatocellular carcinoma (R21) (NCI, NIAAA, NIBIB, NIDDK)

    • Release Date: March 29, 2006
    • Application Receipt Date: Standard dates apply
    • Expiration Date: September 8, 2008
    • Contacts:

      John Cole, Ph.D., Phone: 301-496-1718, Email: jc121b@nih.gov
      Heng Xie, M.D., M.P.H., Ph.D, Phone: 301-496-8866 or 301-496-6512, Email: XieHe@mail.nih.gov

    The several institutes are interested in receiving grant applications that address the etiology and etiologic mechanisms of hepatocellular carcinoma (HCC) and development of animal models, novel approaches to prevent this malignancy, and therapeutic or diagnostic studies aimed at establishing reliable prognostic indicators for disease progression and/or minimizing morbidity and mortality associated with this malignancy.

    See full description in NIH Guide:PA-06-295

  • PA-06-278: Neurotechnology research, development, and enhancement (R21) (NIMH, NIA, NIBIB, NICHD, NIDA, NIDCD, NINDS)

    • Release Date: March 24, 2006
    • Application Receipt Date: Standard dates apply
    • Expiration Date: July 2, 2009
    • Contacts:

      http://www.nih.gov

    The purpose of this Funding Opportunity Announcement (FOA) is to encourage submission of new Exploratory/Developmental (R21) grant applications to research and develop innovative technologies, methodologies, or instrumentation for basic or clinical studies of the brain or behavior in human or non-human animals. Also solicited are applications for support to research, develop, and significantly enhance existing technologies that are important to understanding the brain or behavior.

    See full description in NIH Guide: R21 PA-06-278

  • PAR-05-124: High-End Instrumentation Grant Program (NCRR)

    • Release Date: September 06, 2005
    • Application Receipt Date: September 20,2005

    HIGH-END INSTRUMENTATION GRANT PROGRAM (NCRR) (PAR-05-124)
    Letters of Intent Receipt Date(s): August 15, 2005

    The NCRR High-End Instrumentation Grant (HEI) program solicits applications from groups of NIH-supported investigators to purchase a single major item of equipment to be used for biomedical research that costs at least $750,000. The maximum award is $2,000,000. Instruments in this category include, but are not limited to, structural and functional imaging systems, macromolecular NMR spectrometers, high-resolution mass spectrometers, cryoelectron microscopes and supercomputers. The NCRR intends to commit approximately $21 million in FY2006 to fund approximately 11-16 new awards. Awards are for one year and for direct costs only. Cost sharing is not required. Since the cost of the various instruments will vary, it is anticipated that the size of the award also will vary. This Program Announcement will use the NIH S10 mechanism.

    See full description in NIH Guide:PAR-05-124

  • PAR-05-063: Collaborations with National Centers for Biomedical Computing

    COLLABORATIONS WITH NATIONAL CENTERS FOR BIOMEDICAL COMPUTING (PAR-05-063) (NCI)
    Letters of Intent Receipt Date(s): April 19, 2005; December 19, 2005; same through 2008
    Application Receipt Dates(s): May 17, 2005; January 17, 2006; same through 2008

    The purpose of this program announcement is to provide support for investigators working in collaboration with the NIH National Centers for Biomedical Computing (NCBC) using the R01 mechanism. Details about the specific NIH NCBCs already awarded can be found at http://www.bisti.nih.gov/ncbc/.

    See full description in NIH Guide:PAR-05-063

  • RR-05-001: Technology Development for Biomedical Applications (NCRR)

    • Release Date: September 06, 2005
    • Application Receipt Date: June 22, 2005 and October 19, 2005
    • Expiration Date: N/A
    • Contacts:

      Gregory K. Farber, Ph.D.,NCRR, (farberg@mail.nih.gov), 301-435-0778
      David M. Balshaw, Ph.D., NIEHS, (balshaw@niehs.nih.gov), 9190541-2448

    TECHNOLOGY DEVELOPMENT FOR BIOMEDICAL APPLICATIONS (NCRR)(RFA-RR-05-001)
    Application Receipt Date(s): June 22, 2005 and October 19, 2005

    The purpose of this request for applications (RFA) is to invite innovative applications for (1) the development of new and improved instruments or devices, (2) the development of new methodologies using existing instruments, or (3) the development of software related to instrumentation. Any of these projects should propose tools, methodologies, or software that can be used by a wide range of biomedical or clinical researchers.

    See full description in NIH Guide:RFA-RR-05-001

  • PAR-05-122: Development of PET and SPECT Ligands for Brain Imaging (SBIR/STTR AWARD)

    • Release Date: September 06, 2005
    • Application Receipt Date: February 1, 2005; June 1, 2005; October 1, 2005

    DEVELOPMENT OF PET AND SPECT LIGANDS FOR BRAIN IMAGING (SBIR/STTR AWARD) (NIMH, NIDCD, NIDA, NIA, NINDS) (PA-05-122)
    Standard receipt dates apply.
    This initiative is intended to stimulate the commercial development of novel radioligands for positron emission tomography (PET) and single photon emission computed tomography (SPECT) imaging in human brain, and to incorporate pilot or clinical feasibility evaluation in pre-clinical studies, model development, or clinical studies. The NIH institutes listed in this PA are specifically interested in the development of radioligands for molecular targets (e.g., receptors, cell adhesion molecules, intracellular messengers, and disease related proteins) that are of broad interest to the scientific community. These radiotracers will be used for neuroimaging as well as potential biological markers and surrogate endpoints for translational and clinical research, drug discovery and development, and clinical trials. Also appropriate for this PA are applications proposing research and development of new technologies for radiotracer development.

    See full description in NIH Guide:PA-05-122

  • PA-05-116: Pilot Studies in Pancreatic Cancer (NCI)

    • Release Date: September 06, 2005
    • Application Receipt Date: February 1, June 1, October 1
    • Expiration Date: N/A
    • Contacts:

      see announcement for contacts according to subject

    PILOT STUDIES IN PANCREATIC CANCER (NCI) (PA-05-116)
    The Division of Cancer Control and Population Sciences (DCCPS), Division of Cancer Biology (DCB), Division of Cancer Prevention (DCP), and Division of Cancer Treatment and Diagnosis (DCTD) of the National Cancer Institute (NCI) invite Exploratory Grant (R21) and Small Grant (R03) applications relating to the biology, etiology, detection, prevention, and treatment of pancreatic cancer. These are short-term awards intended to provide support for pilot projects, testing of new techniques, and/or development of innovative projects that could provide a basis for more extended research.

    See full description in NIH Guide:PA-05-116

  • Japan Society Fellowships

    • Release Date: September 06, 2005
    • Application Receipt Date: October 31, 2005
    • Expiration Date: See below
    • Contacts:

      Contact: Maria "Mili" Ferreira, JSPS Program Assistant, Division of International Training and Research, Fogarty International Center, Tel: 301 594-9778; Fax: 301 402-0779; e-mail: ferreima@mail.nih.gov

    The Japan Society for the Promotion of Science (JSPS) conducts fellowship programs for foreign researchers to promote international cooperation in and mutual understanding through scientific research in Japan. Research applications are accepted at the Fogarty International Center (FIC), National Institutes of Health (NIH), which acts as a nominating authority for JSPS programs.

    JSPS Invitation Fellowships

    JSPS conducts short-term (14-60 days) and long-term (61 days -10 months) programs under the Invitation Fellowship Program. The fellowship is funded by a subsidy from the Japanese government, to promote international cooperation and mutual understanding through scientific research. Scientists employed at designated Japanese research institutions and laboratories to invite fellow researchers from the U.S. to Japan to participate in cooperative activities. Application deadline: October 31, 2005

    JSPS Postdoctoral Fellowships

    The JSPS conducts short-term (15 days - 11 months) and long-term (12-24 months) Postdoctoral Fellowships for Foreign Researchers, to assist promising and highly-qualified young researchers wishing to conduct research in Japan. Postdoctoral Fellowship (short-term) Application deadline: October 31, 2005; Postdoctoral Fellowship (long-term) Application deadline: June 30, 2005

    Contact: Maria "Mili" Ferreira, JSPS Program Assistant, Division of International Training and Research, Fogarty International Center, Tel: 301 594-9778; Fax: 301 402-0779; e-mail: ferreima@mail.nih.gov

    Fogarty International Center

  • PAR-05-145: Established Investigator Award In Cancer Prevention & Control (NCI)

    • Release Date: July 28, 2005
    • Application Receipt Date: Standard dates apply for K award
    • Expiration Date: January 8, 2010
    • Contacts:

      Mary C. Blehar, NCI, Phone: 301-496-8580, Email: mblehar@mail.nih.gov

    ESTABLISHED INVESTIGATOR AWARD IN CANCER PREVENTION & CONTROL (NCI) (PAR-05-145)
    Standard application dates.

    The objective of the NCI Established Investigator Award in Cancer Prevention and Control (K05) is to provide qualified researchers with protected time to devote to research and mentoring. The award is designed for established scientists who have already demonstrated a sustained, high level of research and mentoring productivity and who need K05 support to continue these activities. The award provides partial salary support for up to 5 years and for up to 50 percent effort. It is renewable for one additional 5-year period.

    See full description in NIH Guide:PAR-05-145